PDS Biotechnology Corporation is a biotechnology company focused on developing immunotherapeutic drugs for the treatment of various types of cancer and infectious diseases. Their main product is a platform called Versamune™, which combines antigen presentation with immune response activation, allowing for the creation of effective vaccines and immunotherapies. This platform is designed to activate and bolster the patient's immune system to fight against cancer and infections. PDS Biotechnology Corporation aims to develop innovative therapeutic approaches that can improve the treatment of these serious diseases and contribute to better patient health.